Advertisement

A novel natural antisense transcript at human SOX9 locus is down-regulated in cancer and stem cells

  • Mohamad Eftekhary
  • Samira Mohammadi-Yeganeh
  • Zohreh Bolandi
  • Seyed Mahmoud Hashemi
  • Neda Mokhberian
  • Kazem SharifiEmail author
  • Hossein GhanbarianEmail author
Original Research Paper

Abstract

Objective

SOX9 is a key transcription factor with important roles in regulating proliferation and differentiation of various cell types. Dysregulation of SOX9 expression has been involved with pathogenesis of different developmental, degenerative, and neoplastic disorders. Natural antisense transcripts (NATs) are long non-coding RNAs with increasing significance in regulation of gene expression. However, the presence of a NAT at SOX9 locus has been so far unclear.

Result

We detected a natural antisense transcript at SOX9 locus (SOX9-NAT) through strand-specific RT-PCR. In contrast to SOX9 sense RNA (mRNA), SOX9-NAT was down-regulated in cancer tissues and cell lines compared with their normal counterparts. In addition, reciprocal to SOX9 mRNA, SOX9-NAT was also down-regulated in human embryonic stem cells in comparison with human fibroblasts in vitro.

Conclusion

The negative correlation between SOX9 mRNA and SOX9-NAT was confirmed by analyzing qPCR data, as well as RNA-Seq datasets of several human cancers. Our data suggest a functional role for SOX9-NAT in the regulation of SOX9 mRNA as a potential target in cancer treatment and regenerative medicine.

Keywords

SOX9 Natural antisense transcript Cancer Gene expression regulation Stem cells 

Notes

Acknowledgements

This work was financially supported by a Shahid Beheshti University of Medical Sciences, Tehran, Iran (grant number: 14325). Our team appreciates the cellular and molecular biology research center, Tehran, Iran for providing space and facilities.

Author contributions

M.E., S.M.H., K.S., and H.G. comprehended and designed the study. M.E., S.M.H., N.M., Z.B., H.G., and S.M.-Y. performed the experiments. M.E., K.S., S.M.-Y., and H.G. analyzed the data and construed the results. M.E., N.M., Z.B., and H.G. prepared the manuscript. M.E., K.S., and H.G. reviewed during the preparation of manuscript and revised the manuscript.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest concerning the publication of this paper.

Ethical approval

All experiments performed in this study were in agreement with the ethical standards of the Ethics Committee at the Shahid Beheshti University of Medical Sciences and with the 1964 Helsinki declaration.

References

  1. Aguilar-Medina M et al (2019) SOX9 stem-cell factor: clinical and functional relevance in cancer. J Oncol.  https://doi.org/10.1155/2019/6754040 CrossRefPubMedPubMedCentralGoogle Scholar
  2. Balbin OA et al (2015) The landscape of antisense gene expression in human cancers. Genome Res 25:1068–1079CrossRefGoogle Scholar
  3. Bolandi Z, Hosseini Rad SMA, Soudi S, Hashemi SM, Ghanbarian H (2019) A simple and highly efficient method for transduction of human adipose-derived mesenchymal stem cells. J Cell Biochem 120:1726–1734CrossRefGoogle Scholar
  4. Faghihi MA, Wahlestedt C (2009) Regulatory roles of natural antisense transcripts. Nat Rev Mol Cell Biol 10:637–643.  https://doi.org/10.1038/nrm2738 CrossRefPubMedPubMedCentralGoogle Scholar
  5. Ghanbarian H, Grandjean V, Cuzin F, Rassoulzadegan M (2011) A network of regulations by small non-coding RNAs: the P-TEFb kinase in development and pathology. Front Genet 2:95CrossRefGoogle Scholar
  6. Ghanbarian H, Wagner N, Michiels J-F, Cuzin F, Wagner K-D, Rassoulzadegan M (2017) Small RNA-directed epigenetic programming of embryonic stem cell cardiac differentiation. Sci Rep 7:41799CrossRefGoogle Scholar
  7. Jiang SS et al (2010) Upregulation of SOX9 in lung adenocarcinoma and its involvement in the regulation of cell growth and tumorigenicity. Clin Cancer Res 16:4363–4373.  https://doi.org/10.1158/1078-0432.CCR-10-0138 CrossRefPubMedGoogle Scholar
  8. Jo A et al (2014) The versatile functions of Sox9 in development, stem cells, and human diseases. Genes Dis 1:149–161CrossRefGoogle Scholar
  9. Kadaja M et al (2014) SOX9: a stem cell transcriptional regulator of secreted niche signaling factors. Genes Dev 28:328–341.  https://doi.org/10.1101/gad.233247.113 CrossRefPubMedPubMedCentralGoogle Scholar
  10. Keramati F, Seyedjafari E, Fallah P, Soleimani M, Ghanbarian H (2015) 7SK small nuclear RNA inhibits cancer cell proliferation through apoptosis induction. Tumor Biol 36:2809–2814CrossRefGoogle Scholar
  11. Lefebvre V, Dvir-Ginzberg M (2017) SOX9 and the many facets of its regulation in the chondrocyte lineage. Connect Tissue Res 58:2–14CrossRefGoogle Scholar
  12. Lei B, Zhang Y, Liu T, Li Y, Pang D (2016) Sox9 upregulation in breast cancer is correlated with poor prognosis and the CD44 (+)/CD24 (−/low) phenotype. Int J Clin Exp Pathol 9:7345–7351Google Scholar
  13. Li J et al (2015) MicroRNA-494 inhibits cell proliferation and invasion of chondrosarcoma cells in vivo and in vitro by directly targeting SOX9. Oncotarget 6:26216PubMedPubMedCentralGoogle Scholar
  14. Lin S, Zhang L, Luo W, Zhang X (2015) Characteristics of antisense transcript promoters and the regulation of their activity. Int J Mol Sci 17:9CrossRefGoogle Scholar
  15. Liu N et al (2017) MicroRNA-101 inhibits proliferation, migration and invasion of human glioblastoma by targeting SOX9. Oncotarget 8:19244PubMedGoogle Scholar
  16. Lü B et al (2008) Analysis of SOX9 expression in colorectal cancer. Am J Clin Pathol 130:897–904CrossRefGoogle Scholar
  17. Matheu A et al (2012) Oncogenicity of the developmental transcription factor Sox9. Cancer Res 72:1301–1315.  https://doi.org/10.1158/0008-5472.CAN-11-3660 CrossRefPubMedPubMedCentralGoogle Scholar
  18. Mokhberian N, Hashemi SM, Jajarmi V, Eftekhary M, Koochaki A, Ghanbarian H (2019) Sirt1 antisense transcript is down-regulated in human tumors. Mol Biol Rep 46(2):2299–2305CrossRefGoogle Scholar
  19. Pelechano V, Steinmetz LM (2013) Gene regulation by antisense transcription. Nat Rev Genet 14:880–893.  https://doi.org/10.1038/nrg3594 CrossRefPubMedGoogle Scholar
  20. Pritchett J, Athwal V, Roberts N, Hanley NA, Hanley KP (2011) Understanding the role of SOX9 in acquired diseases: lessons from development. Trends Mol Med 17:166–174CrossRefGoogle Scholar
  21. Richtig G et al (2017) SOX9 is a proliferation and stem cell factor in hepatocellular carcinoma and possess widespread prognostic significance in different cancer types. PLoS ONE 12:e0187814CrossRefGoogle Scholar
  22. Sashikawa Kimura M, Mutoh H, Sugano K (2011) SOX9 is expressed in normal stomach, intestinal metaplasia, and gastric carcinoma in humans. J Gastroenterol 46:1292–1299.  https://doi.org/10.1007/s00535-011-0443-5 CrossRefPubMedGoogle Scholar
  23. Wang J et al (2017) Upregulation of microRNA-524-5p enhances the cisplatin sensitivity of gastric cancer cells by modulating proliferation and metastasis via targeting SOX9. Oncotarget 8:574PubMedGoogle Scholar
  24. Wanowska E, Kubiak MR, Rosikiewicz W, Makałowska I, Szcześniak MW (2018) Natural antisense transcripts in diseases: from modes of action to targeted therapies. Wiley Interdiscip Rev RNA 9:e1461CrossRefGoogle Scholar
  25. Yang B, Guo H, Zhang Y, Chen L, Ying D, Dong S (2011) MicroRNA-145 regulates chondrogenic differentiation of mesenchymal stem cells by targeting Sox9. PLoS ONE 6:e21679CrossRefGoogle Scholar
  26. Zhang W, Cheng P, Hu W, Yin W, Guo F, Chen A, Huang H (2018) Inhibition of microRNA-384-5p alleviates osteoarthritis through its effects on inhibiting apoptosis of cartilage cells via the NF-κB signaling pathway by targeting SOX9. Cancer Gene Ther 25:326CrossRefGoogle Scholar

Copyright information

© Springer Nature B.V. 2019

Authors and Affiliations

  • Mohamad Eftekhary
    • 1
  • Samira Mohammadi-Yeganeh
    • 1
    • 2
  • Zohreh Bolandi
    • 2
  • Seyed Mahmoud Hashemi
    • 3
    • 4
    • 5
  • Neda Mokhberian
    • 2
  • Kazem Sharifi
    • 1
    • 2
    Email author
  • Hossein Ghanbarian
    • 1
    • 5
    Email author
  1. 1.Department of Biotechnology, School of Advanced Technologies in MedicineShahid Beheshti University of Medical SciencesTehranIran
  2. 2.Cellular and Molecular Biology Research CenterShahid Beheshti University of Medical SciencesTehranIran
  3. 3.Department of Immunology, School of MedicineShahid Beheshti University of Medical SciencesTehranIran
  4. 4.Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in MedicineShahid Beheshti University of Medical SciencesTehranIran
  5. 5.Urogenital Stem Cell Research CenterShahid Beheshti University of Medical SciencesTehranIran

Personalised recommendations